Skip to main content
. Author manuscript; available in PMC: 2021 May 3.
Published in final edited form as: J Allergy Clin Immunol Pract. 2020 Nov 17;9(4):1731–1733.e3. doi: 10.1016/j.jaip.2020.11.011

Table 1.

Anti-PEG IgE and Anti-PEG IgG in Sera from Cases and Controls of PEG-associated Anaphylaxis.

Clinic Anti-PEG IgE Anti-PEG IgG
Lab ID Positivity (Max MFI) Titration Inhibition Positivity (Max MFI) Titration Inhibition
PEG1 Case +++
(4,855)
>512 100% ++
(154,969)
>16,384 100%
PEG2 Case +
(1,076)
>32 100% ++
(109,079)
>8,192 100%
PEG3 Control +/−
(295)
>4 ND +
(39,826)
>2,048 100%
PEG4 Control
(−86)
ND
(130)
1 ND
PEG5 Control
(0)
ND
(4,603)
>1 ND
PEG6 Case ++
(493)
>90 100% +++
(40,419)
>10,000 100%
PEG7 Case ++
(291)
>100 100% +++
(78,647)
>10,000 100%
PEG8 Case ++
(1,800)
>90 100% +
(29,494)
>2,500 100%
PEG9 Case +
(4,058)
>30 100% ++
(160,690)
>6,000 100%

Note: Number of “+” was assigned based upon the titer., for IgE a titer >30 is +, >90 is ++, >512 is +++; for IgG a titer >2000 is +, >6000 is ++, >10000 is +++. Max MFI is the maximum difference of target and control beads. Titer is the dilution where target-control bead MFI becomes flat. “ND”, not done.